K DeSombre
About
In The Last Decade
K DeSombre
12 papers receiving 418 citations
Peers
Comparison fields: 5 of 58
- Oncology 203
- Molecular Biology 161
- Radiology, Nuclear Medicine and Imaging 131
- Immunology 96
- Pathology and Forensic Medicine 87
Countries citing papers authored by K DeSombre
This map shows the geographic impact of K DeSombre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K DeSombre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K DeSombre more than expected).
Fields of papers citing papers by K DeSombre
This network shows the impact of papers produced by K DeSombre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K DeSombre. The network helps show where K DeSombre may publish in the future.
Co-authorship network of co-authors of K DeSombre
This figure shows the co-authorship network connecting the top 25 collaborators of K DeSombre. A scholar is included among the top collaborators of K DeSombre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K DeSombre. K DeSombre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Title | Journal | Authors | Indexed citations |
|---|---|---|---|---|
| 1 | Association of Polymorphisms in the Apolipoprotein E Region with Susceptibility to and Progression of Multiple Sclerosis | The American Journal of Human Genetics | Silke Schmidt, Lisa F. Barcellos et al. | 104 |
| 2 | Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2. | PubMed | Fengfeng Xu, Steven A. Leadon et al. | 11 |
| 3 | Relative cytotoxic activity of immunotoxins reactive with different epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185 | International Journal of Cancer | Cinda M. Boyer, Lajos Pusztai et al. | 21 |
| 4 | Cell surface density of p185(c-erbB-2) determines susceptibility to anti-p185(c-erbB-2)-ricin A chain (RTA) immunotoxin therapy alone and in combination with anti-p170(EGFR)-RTA in ovarian cancer cells. | PubMed | Gillian S. Dean, Lajos Pusztai et al. | 24 |
| 5 | Ex vivo expansion of bone marrow from breast cancer patients: reduction in tumor cell content through passive purging | Bone Marrow Transplantation | K DeSombre, A. K. Smith et al. | 22 |
| 6 | The significance of tumor contamination in the bone marrow from high-risk primary breast cancer patients treated with high-dose chemotherapy and hematopoietic support. | PubMed | James J. Vredenburgh, Gloria Broadwater et al. | 34 |
| 7 | A Comparison of Immunohistochemistry, Two-Color Immunofluorescence, and Flow Cytometry with Cell Sorting for the Detection of Micrometastatic Breast Cancer in the Bone Marrow | Journal of Hematotherapy | James J. Vredenburgh, K DeSombre et al. | 25 |
| 8 | Detection of tumor cells in the bone marrow of stage IV breast cancer patients receiving high-dose chemotherapy: the role of induction chemotherapy. | PubMed | James J. Vredenburgh, W. P. Peters et al. | 12 |
| 9 | Serum levels of HER-2neu (C-erbB-2) correlate with overexpression of p185neu in human ovarian cancer | Cancer | S J McKenzie, K DeSombre et al. | 74 |
| 10 | Antibody‐induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c‐erbb‐2 (her‐2/neu) gene product p185 | International Journal of Cancer | Fengji Xu, Ruth Lupu et al. | 53 |
| 11 | OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance procedures. | Journal of Clinical Oncology | Feng Xu, Yan Yu et al. | 38 |
| 12 | A combination of two immunotoxins exerts synergistic cytotoxic activity against human breast‐cancer cell lines | International Journal of Cancer | Jennie R. Crews, Lisa A. Maier et al. | 14 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.